JP
JPMORGAN CHASE & CO
JPMOwnership as of Q2 2026
Funds owning
15
Combined value
1.6B
Avg portfolio %
0.9%
Buys / Sells this quarter
−1 sells
Q2-2026
| Investor | Weight | Q/Q change | Value |
|---|---|---|---|
MA Matrix Asset Advisors – David Katz | Trial 3.54% | ↘Reduced 1.22% | 132.9K shares · $327.33 $43.5M |
M& Mairs & Poweras of Q1-2026 | Trial 3.17% | ↘Reduced 17.41% | 1.1M shares · $294.16 $310.1M |
VG Viking Global Investorsas of Q1-2026 | Trial 2.23% | ↗Added 41.87% | 2.7M shares · $294.16 $795.4M |
TI Torray Investment Partnersas of Q1-2026 | Trial 1.68% | 38.9K shares · $294.16 $11.4M | |
DS Davis Selected Advisersas of Q1-2026 | Trial 0.75% | ↘Reduced 2.65% | 556.5K shares · $294.16 $163.7M |
MG Markel Group – Tom Gayneras of Q1-2026 | Trial 0.62% | 252.6K shares · $294.16 $74.3M | |
GC Giverny Capitalas of Q1-2026 | Trial 0.56% | ↗Added 0.89% | 52.3K shares · $294.16 $15.4M |
GR Gardner Russo & Quinn – Thomas Russoas of Q1-2026 | Trial 0.52% | ↘Reduced 71.86% | 148.8K shares · $294.16 $43.8M |
PC Patient Capital Managementas of Q1-2026 | Trial 0.32% | ↘Reduced 0.06% | 29.4K shares · $294.16 $8.6M |
PI Pzena Investment Managementas of Q1-2026 | Trial 0.32% | ↘Reduced 1.50% | 337.3K shares · $294.16 $99.2M |
KB Kahn Brothers Groupas of Q1-2026 | Trial 0.15% | ↘Reduced 18.74% | 2.8K shares · $294.16 $828,942 |
BW Brave Warrior Advisors – Glenn Greenbergas of Q1-2026 | Trial 0.04% | 5.6K shares · $294.16 $1.7M | |
D& Dodge & Coxas of Q1-2026 | Trial 0.02% | ↘Reduced 4.78% | 118.5K shares · $294.16 $34.8M |
GA Greenhaven Associatesas of Q1-2026 | Trial 0.02% | 4.0K shares · $294.16 $1.2M | |
HA Harris Associatesas of Q1-2026 | Trial 0.00% | ↘Reduced 2.02% | 5.8K shares · $294.16 $1.7M |
| 15 funds | $1.6B |